Brief Behavioral Treatment for Insomnia in Cancer Survivors
Efficacy of Nurse-Delivered Brief Behavioral Treatment to Self-Manage Insomnia in Cancer Survivors
2 other identifiers
interventional
132
1 country
2
Brief Summary
The purpose is to determine whether brief behavioral treatment is effective for insomnia in cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2019
CompletedFirst Posted
Study publicly available on registry
January 18, 2019
CompletedStudy Start
First participant enrolled
June 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedResults Posted
Study results publicly available
November 30, 2023
CompletedJuly 3, 2024
June 1, 2024
3.5 years
January 14, 2019
September 26, 2023
June 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia Severity Index
One month after the intervention, experimental group mean for Insomnia Severity Index will be compared to control group mean Insomnia Severity Index. The Insomnia Severity Index is a self report brief screening tool with seven items that asks respondents to rate the nature and symptoms of their sleep problems and the degree to which insomnia interferes with daily functioning and overall distress created by sleep problems using a likert type scale Scores between 0-7 have no clinically significant insomnia. Scores between 8-14 have sub threshold insomnia. Scores between 15-21 have moderate clinical insomnia. Scores between 22-28 have severe clinical insomnia.
one month
Study Arms (2)
Behavioral: Brief behavioral treatment for insomnia
EXPERIMENTALBrief behavioral treatment for insomnia includes 45 minute individual intervention with two follow up phone calls.
Behavioral: Healthy eating control
ACTIVE COMPARATORHealthy eating control involves a 45 minute individual session with two follow up phone calls.
Interventions
Brief Behavioral Treatment for Insomnia includes content on sleep restriction, stimulus control, and sleep hygiene content with 1 month for primary outcome followed by 3 month 12 month follow-up visits.
Healthy eating control involves healthy eating content with 1 month for primary outcome followed by 3 month and 12 month follow-up visits.
Eligibility Criteria
You may qualify if:
- \> or = 4 weeks from surgery for cancer treatment; chemotherapy and/or radiation therapy; no wait for hormone therapy or targeted treatment for stage I, II, or III: breast, colorectal, prostate, lung cancer
- chronic insomnia
You may not qualify if:
- Other preexisting sleep disorders except those with OSA stable on CPAP
- Unstable medical illnesses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University at Buffalo
Buffalo, New York, 14214, United States
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14263, United States
Related Publications (5)
Cai Z, Tang Y, Liu C, Li H, Zhao G, Zhao Z, Zhang B. Cognitive behavioural therapy for insomnia in people with cancer. Cochrane Database Syst Rev. 2025 Oct 31;10(10):CD015176. doi: 10.1002/14651858.CD015176.pub2.
PMID: 41170811DERIVEDKwon M, Zhu J, Wilding GE, Larkin K, Gehrman PR, Dickerson SS. Health-related quality of life and mental health outcomes among cancer survivors in an insomnia intervention: a randomized controlled trial. Ann Behav Med. 2025 Jan 4;59(1):kaae096. doi: 10.1093/abm/kaae096.
PMID: 39887070DERIVEDDickerson SS, Kwon M, Wilding GE, Zhu J. Nurse-delivered brief behavioral treatment for insomnia in cancer survivors: a randomized controlled trial. J Cancer Surviv. 2024 Nov 26. doi: 10.1007/s11764-024-01704-1. Online ahead of print.
PMID: 39589721DERIVEDKwon M, Zhu J, Wilding GE, Dickerson SS, Dean GE. Sleep-wake state discrepancy among cancer survivors with insomnia symptoms. Support Care Cancer. 2023 Dec 4;32(1):2. doi: 10.1007/s00520-023-08177-5.
PMID: 38047967DERIVEDKwon M, Dickerson SS, Wilding GE, Aquilina AT, Reid M, Dean GE. A nurse-delivered intervention to reduce insomnia in cancer survivors: Study protocol for a randomized-controlled trial. Contemp Clin Trials. 2022 Nov;122:106939. doi: 10.1016/j.cct.2022.106939. Epub 2022 Sep 28.
PMID: 36182027DERIVED
Related Links
- Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial.
- A primary care "friendly" cognitive behavioral insomnia therapy.
- Effects of a brief behavioral treatment for PTSD-related sleep disturbances: a pilot study.
- Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer.
- How to provide insomnia interventions to people with cancer: insights from patients.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Suzanne S. Dickerson
- Organization
- School of Nursing, University at Buffalo
Study Officials
- PRINCIPAL INVESTIGATOR
Suzanne S. Dickerson, PhD
University at Buffalo, School of Nursing
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 14, 2019
First Posted
January 18, 2019
Study Start
June 6, 2019
Primary Completion
November 17, 2022
Study Completion
November 1, 2023
Last Updated
July 3, 2024
Results First Posted
November 30, 2023
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share